Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W, Bechter O, SГ¶derberg O, Nilsson K, Terol M, Greil R, Thaler J, Herold M, Finke L, GГјnthert U, Montserrat E, Stauder R. Leuk Res. 2004 Oct,28(10):1043-51.
View this publication in the PUBMED databaseBiomarkers in non-small cell lung cancer prevention.
Hilbe W, Dirnhofer S, Greil R, WГ¶ll E. Eur J Cancer Prev. 2004 Oct,13(5):425-36.
View this publication in the PUBMED databaseIs higher income and educational status associated with poorer outcome in patients with Hodgkin’s disease?
Holzner B, Fischhofer M, Kemmler G, Kopp M, Sperner-Unterweger B, Krugmann J, Dirnhofer S, Greil R. Eur J Haematol. 2004 Nov,73(5):318-24.
View this publication in the PUBMED databaseInterleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia.
Anether G, Marschitz I, Tinhofer I, Greil R. Blood. 2002 Jan 15,99(2):722-3.
View this publication in the PUBMED databaseThe role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia.
Schwarzmeier JD, Shehata M, Hilgarth M, Marschitz I, Louda N, Hubmann R, Greil R. Leuk Lymphoma. 2002 Mar,43(3):549-54.
View this publication in the PUBMED databaseStressful death of T-ALL tumor cells after treatment with the anti-tumor agent Tetrocarcin-A.
Tinhofer I, Anether G, Senfter M, Pfaller K, Bernhard D, Hara M, Greil R. FASEB J. 2002 Aug,16(10):1295-7. Epub 2002 Jun 7.
View this publication in the PUBMED databaseMultidimensional scaling as a tool for analysing quality of life data.
Kemmler G, Holzner B, Kopp M, DГјnser M, Greil R, Hahn E, Sperner-Unterweger B. Qual Life Res. 2002 May,11(3):223-33.
View this publication in the PUBMED databaseMonoclonal gammopathy of undetermined significance.
Fiegl M, Greil R. N Engl J Med. 2002 Jun 27,346(26):2087-8, author reply 2087-8.
View this publication in the PUBMED databaseGastric cancer cell lines lack Fas ligand (FasL) expression but kill T cells via a FasL independent pathway.
Tinhofer I, Wykypiel H, Marschitz I, Henn T, Greil R. Gut. 2000 May,46(5):738-40.
View this publication in the PUBMED databaseVinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer.
Krajnik G, Mohn-Staudner A, Thaler J, Greil R, Schmeikal S, Marhold F, Deutsch J, Preiss P, Malayeri R, Schäfer-Prokop C, Wein W, Huber H, Pirker R. Ann Oncol. 2000 Aug,11(8):993-8.
View this publication in the PUBMED database